The Enterprise Value as of April 2026 (TTM) for Zhengye Biotechnology Holding Limited (ZYBT) is 381.35M

According to Zhengye Biotechnology Holding Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 381.35M. This represents a change of 480.09% compared to the average of 65.74M of the last 4 quarters.

Zhengye Biotechnology Holding Limited (ZYBT) Historical Enterprise Value (quarterly & annually)

How has ZYBT Enterprise Value performed in the past?

The mean historical Enterprise Value of Zhengye Biotechnology Holding Limited over the last ten years is 1.60B. The current 381.35M Enterprise Value has changed 2.28% with respect to the historical average. Over the past ten years (40 quarters), ZYBT's Enterprise Value was at its highest in in the June 2024 quarter at 80.20M. The Enterprise Value was at its lowest in in the June 2025 quarter at 40.16M.

Zhengye Biotechnology Holding Limited (ZYBT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zhengye Biotechnology Holding Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhengye Biotechnology Holding Limited (ZYBT) Average Enterprise Value

How has ZYBT Enterprise Value performed in the past?

The current Enterprise Value of Zhengye Biotechnology Holding Limited (ZYBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Zhengye Biotechnology Holding Limited (ZYBT) Enterprise Value vs. Peers

How is ZYBT’s Enterprise Value compared to its peers?

Zhengye Biotechnology Holding Limited’s Enterprise Value is greater than Incannex Healthcare Limited (-18616464.00), greater than Cardiol Therapeutics Inc. (187.55M), greater than Pro-Dex, Inc. (161.87M), greater than Surrozen, Inc. (164.90M), greater than Sera Prognostics, Inc. (75.54M), greater than eXoZymes, Inc. (80.87M), greater than Atossa Therapeutics, Inc. (5.20M), greater than Apyx Medical Corporation (150.24M), greater than Instil Bio, Inc. (132.49M), greater than Oncolytics Biotech Inc. (120.13M),

Build a custom stock screener for Zhengye Biotechnology Holding Limited (ZYBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhengye Biotechnology Holding Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhengye Biotechnology Holding Limited (ZYBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhengye Biotechnology Holding Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.